Navigation Links
China Yingxia International, Inc. Announces $2 Million Share Repurchase Program
Date:10/9/2008

HARBIN, China, Oct. 9 /Xinhua-PRNewswire-FirstCall/ -- China Yingxia International, Inc. (OTC Bulletin Board: CYXI) ("China Yingxia" or "the Company"), a leading provider in the health and nutritional food industry engaged in the development, manufacture and distribution of nutritional food products, dietary supplements, and raw cactus plants in the People's Republic of China ("PRC"), today announced that the Board of Directors of the Company has approved and authorized a share repurchase program for up to $2 million of its common stock.

China Yingxia will repurchase shares on the open market or through privately negotiated transactions through September 30, 2009, in compliance with the rules and regulations of the U.S. Securities and Exchange Commission. The final number of shares repurchased and the timing of the purchases will depend on market conditions, share price, applicable legal requirements, and other factors deemed appropriate by the Board of Directors. The repurchase program may be discontinued or expanded by the Board of Directors in the future.

The repurchases will be funded with available cash on hand. As of August 14, 2008, the Company had 44.5 million common shares outstanding and approximately 10.9 million freely traded shares. Any shares repurchased by the Company in this program will reduce the number common shares outstanding.

"Our strong balance sheet provides us with the opportunity to return value to our shareholders through a stock repurchase program without impacting our ability to engage in new investments for future growth. We have recently completed the most capital intensive phase of our growth plan by increasing production capacity. Now we will focus on expanding our franchisee-based distribution network and product offerings," said Ms. Yinxia Jiao, CEO and Chairwoman of China Yingxia. "We expect our cash position to further improve in the near future due to profitable operations, reduction in inventory and
'/>"/>

SOURCE China Yingxia International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
5. China Technology Announces New Chief Financial Officer
6. China Medical Technologies Reports First Quarter Financial Results
7. China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference
8. China Technology Announces Entry to the Solar Energy Sector
9. China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products
10. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
11. China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., TSXVENTURE:HTL , TORONTO,Nov.24/PRNewswir...yCalottoCapitalInc.,aleadingproviderofadvancedlase...tilityclinicmarkets,todayreportedoperationalandfin...09. , ,Q32009Highlights,-Revenuewas$1.46millionc...was66.3percentcomparedwith66.1percentinQ3,2008,-Ne...
(Date:11/24/2009)..., REDWOODCITY,Calif.,Nov.24/PRNewswire-FirstCall...thatRandyScott,GenomicHealth,sExecutiveChairman,wi...erenceinNewYorkCityonTuesday,December1,2009at10:00...edwebcastofthepresentation,visittheInvestorRelatio...r.genomichealth.com .Pleaseconnecttothewebsiteatle...
(Date:11/24/2009)... Chemical Abstracts Service (...eports that China,s patent office is now the world...ns in chemistry. China trailed Japan,s patent offi...WIPO), and the United States Patent and Trademark ...the USPTO in 2005, WIPO in 2006, and exceeded Japa...
(Date:11/23/2009)...AMPAIGN, Ill. You can think of it as origami ver...ity of Illinois have developed a technique for fab...icon structures from thin films by coupling photol...pillary interactions. , The films, only a few mic...ot possible with thicker pieces of the same materi...
Breaking Biology Technology:Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Genomic Health to Present at Piper Jaffray Health Care Conference 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3Water droplets direct self-assembly process in thin-film materials 2
...CHICAGO, Aug. 6 Advanced Life Sciences,Holdings, ... engaged in the,discovery, development and commerc... of infection, cancer and respiratory diseases tod...nd webcast discussing the,Company,s 2008 second qu...0,a.m. (EDT). Michael T. Flavin, Ph.D., Chairman &...
...QUEBEC CITY, Aug. 5 /PRNewswire-FirstCall/ - AEter...bal biopharmaceutical company focused on,endocrine...arter 2008,financial and operating results after m...y will host a conference call and webcast to discu... Eastern Time., Participants may access the confe...
...Leading Non-Fusion Spine Surgeon Supports Company,...search, Education, SAN DIEGO, Aug. 6 SpineMark C...t partners with hospitals and physicians to,develo...l education,training centers, has appointed Dr. Ru...(Bogen, Germany), as chairman of its International...
Other Biology Technology:Advanced Life Sciences To Host 2008 Second Quarter Financial Results Conference Call and Webcast 2Advanced Life Sciences To Host 2008 Second Quarter Financial Results Conference Call and Webcast 3SpineMark Appoints Dr. Rudolf Bertagnoli Chairman of International Medical Advisory Board 2
(Date:11/24/2009)... , The presence of increased body fat, and ther...the blood, hinders the loss and maintenance of bod...iversity of Navarra conducted by Estbaliz Goyenech... The project, entitled "A nutrigenetic and nutrig...ight and inflammation," examines how the individua...
(Date:11/23/2009)...strain of the deadly superbug MRSAan infection-cau...poses a far greater health threat than previously ...ing to a study in the December issue of Emerging ...y picked up in fitness centers, schools, and other...n of MRSA within hospitals, the report found. , ...
(Date:11/23/2009)...day matters to forest trees dealing with drought, ...am led by Professor Malcolm Campbell, University o...h and colleagues in the department of cell and sys...alizing on their previous work to decode the genom...ow poplar trees use their 45,000 genes to respond ...
Breaking Biology News(10 mins):It can be predicted the reaction obese patients will have to a diet 2New study finds MRSA on the rise in hospital outpatients 2Time of day matters to thirsty trees, U of T researcher discovers 2Reportlinker Adds World Cancer Therapies Market Report 56747 1Reportlinker Adds World Cancer Therapies Market Report 56747 2Reportlinker Adds World Cancer Therapies Market Report 56747 3Reportlinker Adds World Cancer Therapies Market Report 56747 4Reportlinker Adds World Cancer Therapies Market Report 56747 5Reportlinker Adds World Cancer Therapies Market Report 56747 6Reportlinker Adds World Cancer Therapies Market Report 56747 7Reportlinker Adds World Cancer Therapies Market Report 56747 8Reportlinker Adds World Cancer Therapies Market Report 56747 9Reportlinker Adds World Cancer Therapies Market Report 56747 10Reportlinker Adds World Cancer Therapies Market Report 56747 11Reportlinker Adds World Cancer Therapies Market Report 56747 12Reportlinker Adds World Cancer Therapies Market Report 56747 13Reportlinker Adds World Cancer Therapies Market Report 56747 14Reportlinker Adds World Cancer Therapies Market Report 56747 15Esperance Pharmaceuticals Announces Initiation of Clinical Studies of its Novel Membrane disrupting Agent EP 100 in Patients with Cancer 13972 1Esperance Pharmaceuticals Announces Initiation of Clinical Studies of its Novel Membrane disrupting Agent EP 100 in Patients with Cancer 13972 2Esperance Pharmaceuticals Announces Initiation of Clinical Studies of its Novel Membrane disrupting Agent EP 100 in Patients with Cancer 13972 3Wings of Mercy Benefit Features Miracle on the Hudson Heroes 56743 1Wings of Mercy Benefit Features Miracle on the Hudson Heroes 56743 2Wings of Mercy Benefit Features Miracle on the Hudson Heroes 56743 3
...ic gene mutation may be useful in predicting the l...e treatment options and follow-up care, according ...AF V600E, is a genetic alteration in the BRAF onco...e new research is reported in the September issue ...wn that the mutation frequently occurs in the most...
...Sept. 5, 2007) As if being admitted to the hospit... at higher risk of becoming infected with a superb.... The toxins produced by C. difficile kill human i...owing the bacteria to use them as fuel. This resul...braham Linc Sonenshein, PhD, and colleagues from t...
...ynamic world of the developing brain, neural stem ...fluid-filled ventricles. These newborn neurons the...cortex, the seat of higher cognitive functions. No...his migration one that may also play an important...s, including cancer. , The finding, the cover st...
Other Biology News:Presence of gene mutation helps guide thyroid cancer treatment 2Presence of gene mutation helps guide thyroid cancer treatment 3Curbing C. difficile's toxin production 2Neural stem cell study reveals mechanism that may play role in cancer 2Neural stem cell study reveals mechanism that may play role in cancer 3Neural stem cell study reveals mechanism that may play role in cancer 4
Chicken Anti-Human QPRT Polyclonal Antibody, Unconjugated from ProSci, Inc
Anti-J Chain Monoclonal Antibody, Unconjugated, Clone M19/9J from CHEMICON
Agarose from BioPioneer
... tissue sections and cell preparations immunohisto...ol soluble OR alcohol insoluble end products. Ul...Fast Red or AEC that require an aqueous mounting m...ng is required prior to use. This product is optim...
Biology Products: